FDA approves Genzyme’s AUBAGIO® (teriflunomide), a once-daily, oral treatment for relapsing multiple sclerosis Genzyme, 12 Sep 2012 Accessed on 14 Sep 2012 from http://www.businesswire.com/news/genzyme/20120912007076/en. CommentRecommendBookmarkWatch